Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Heinrich

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Applied and Environmental Microbiology|August 14, 2016
Synthesis Gas (Syngas)-Derived Medium-Chain-Length Polyhydroxyalkanoate Synthesis in Engineered Rhodospirillum rubrumDaniel Heinrich, Matthias Raberg, Philipp Fricke, et al.
Cancer Management and Research|January 28, 2025
Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3)Katarina Puco, Cathrine S Notland, Robert Szulkin, et al.
European Urology Oncology|August 15, 2019
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working GroupJoe M O'Sullivan, Joan Carles, Richard Cathomas, et al.
Journal of Psychiatric Research|March 24, 2021
Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism - Implications for depression and anxietyHarald Murck, Christian Adolf, Anna Schneider, et al.
Plos One|June 22, 2012
Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertensionCornelia Schuster, Hans P Eikesdal, Hanne Puntervoll, et al.
BMC Cancer|January 8, 2019
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access programAxel Heidenreich, Silke Gillessen, Daniel Heinrich, et al.
Clinical Genitourinary Cancer|July 18, 2019
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access ProgramFred Saad, Silke Gillessen, Daniel Heinrich, et al.
Advances in Radiation Oncology|June 13, 2020
Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate CancerChristian Ekanger, Svein Inge Helle, Daniel Heinrich, et al.
Applied Microbiology and Biotechnology|August 3, 2016
Understanding the physiological roles of polyhydroxybutyrate (PHB) in Rhodospirillum rubrum S1 under aerobic chemoheterotrophic conditionsTanja Narancic, Elisa Scollica, Shane T Kenny, et al.
Clinical Endocrinology|January 2, 2024
Effect of mild cortisol cosecretion on body composition and metabolic parameters in patients with primary hyperaldosteronismNabeel Mansour, Denise Bruedgam, Ulrich Dischinger, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Applied and Environmental Microbiology|August 14, 2016
Synthesis Gas (Syngas)-Derived Medium-Chain-Length Polyhydroxyalkanoate Synthesis in Engineered Rhodospirillum rubrumDaniel Heinrich, Matthias Raberg, Philipp Fricke, et al.
Cancer Management and Research|January 28, 2025
Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3)Katarina Puco, Cathrine S Notland, Robert Szulkin, et al.
European Urology Oncology|August 15, 2019
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working GroupJoe M O'Sullivan, Joan Carles, Richard Cathomas, et al.
Journal of Psychiatric Research|March 24, 2021
Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism - Implications for depression and anxietyHarald Murck, Christian Adolf, Anna Schneider, et al.
Plos One|June 22, 2012
Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertensionCornelia Schuster, Hans P Eikesdal, Hanne Puntervoll, et al.
BMC Cancer|January 8, 2019
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access programAxel Heidenreich, Silke Gillessen, Daniel Heinrich, et al.
Clinical Genitourinary Cancer|July 18, 2019
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access ProgramFred Saad, Silke Gillessen, Daniel Heinrich, et al.
Advances in Radiation Oncology|June 13, 2020
Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate CancerChristian Ekanger, Svein Inge Helle, Daniel Heinrich, et al.
Applied Microbiology and Biotechnology|August 3, 2016
Understanding the physiological roles of polyhydroxybutyrate (PHB) in Rhodospirillum rubrum S1 under aerobic chemoheterotrophic conditionsTanja Narancic, Elisa Scollica, Shane T Kenny, et al.
Clinical Endocrinology|January 2, 2024
Effect of mild cortisol cosecretion on body composition and metabolic parameters in patients with primary hyperaldosteronismNabeel Mansour, Denise Bruedgam, Ulrich Dischinger, et al.
Pageof 6